Lena Oevermann

869 total citations
28 papers, 534 citations indexed

About

Lena Oevermann is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Lena Oevermann has authored 28 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 12 papers in Genetics and 8 papers in Immunology. Recurrent topics in Lena Oevermann's work include Hemoglobinopathies and Related Disorders (12 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Iron Metabolism and Disorders (7 papers). Lena Oevermann is often cited by papers focused on Hemoglobinopathies and Related Disorders (12 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Iron Metabolism and Disorders (7 papers). Lena Oevermann collaborates with scholars based in Germany, United States and Martinique. Lena Oevermann's co-authors include Rupert Handgretinger, Peter Lang, Christoph A. Ritter, Werner Siegmund, Heyo K. Kroemer, Gabriele Jedlitschky, Markus Mezger, Markus Grube, Franco Locatelli and Lorenzo Moretta and has published in prestigious journals such as Blood, Annals of the New York Academy of Sciences and International Journal of Cancer.

In The Last Decade

Lena Oevermann

24 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lena Oevermann Germany 12 236 207 198 144 108 28 534
Maryam Behfar Iran 10 161 0.7× 156 0.8× 69 0.3× 141 1.0× 72 0.7× 68 415
Walid Rasheed Saudi Arabia 13 202 0.9× 58 0.3× 163 0.8× 359 2.5× 69 0.6× 49 608
LD Notarangelo Italy 13 137 0.6× 254 1.2× 85 0.4× 97 0.7× 100 0.9× 19 534
Bérengère de Laval France 8 123 0.5× 297 1.4× 56 0.3× 217 1.5× 47 0.4× 10 545
Sara Raponi Italy 15 225 1.0× 231 1.1× 244 1.2× 108 0.8× 252 2.3× 24 626
Giridharan Ramsingh United States 15 316 1.3× 167 0.8× 130 0.7× 328 2.3× 103 1.0× 52 691
Toshiya Yokozawa Japan 8 222 0.9× 63 0.3× 100 0.5× 281 2.0× 107 1.0× 17 528
Kun Soo Lee South Korea 12 287 1.2× 126 0.6× 98 0.5× 70 0.5× 60 0.6× 43 449
Kenneth Heym United States 10 157 0.7× 85 0.4× 135 0.7× 102 0.7× 40 0.4× 26 366

Countries citing papers authored by Lena Oevermann

Since Specialization
Citations

This map shows the geographic impact of Lena Oevermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lena Oevermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lena Oevermann more than expected).

Fields of papers citing papers by Lena Oevermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lena Oevermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lena Oevermann. The network helps show where Lena Oevermann may publish in the future.

Co-authorship network of co-authors of Lena Oevermann

This figure shows the co-authorship network connecting the top 25 collaborators of Lena Oevermann. A scholar is included among the top collaborators of Lena Oevermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lena Oevermann. Lena Oevermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Allali, Slimane, Frédéric Galactéros, Lena Oevermann, et al.. (2024). Hydroxyurea is associated with later onset of acute splenic sequestration crisis in sickle cell disease: Lessons from the European Sickle Cell Disease Cohort—Hydroxyurea (ESCORT‐HU) study. American Journal of Hematology. 99(4). 555–561. 4 indexed citations
4.
5.
Alashkar, Ferras, et al.. (2022). Transition in Sickle Cell Disease (SCD): A German Consensus Recommendation. Journal of Personalized Medicine. 12(7). 1156–1156. 3 indexed citations
6.
Montalembert, Mariane de, Ersi Voskaridou, Lena Oevermann, et al.. (2021). Real‐Life experience with hydroxyurea in patients with sickle cell disease: Results from the prospective ESCORT‐HU cohort study. American Journal of Hematology. 96(10). 1223–1231. 34 indexed citations
7.
Allard, Pierre, Stephan Lobitz, Holger Cario, et al.. (2021). Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea. Haematologica. 107(7). 1577–1588. 12 indexed citations
8.
Kunz, Joachim B., Stephan Lobitz, Andrea Jarisch, et al.. (2021). Benefits of a Disease Management Program for Sickle Cell Disease in Germany 2011–2019: The Increased Use of Hydroxyurea Correlates with a Reduced Frequency of Acute Chest Syndrome. Journal of Clinical Medicine. 10(19). 4543–4543. 8 indexed citations
9.
Landwehr-Kenzel, Sybille, Stephanie Thee, Lena Oevermann, et al.. (2021). Hematopoietic Stem Cell Transplantation Cures Therapy-refractory Aspergillosis in Chronic Granulomatous Disease. The Pediatric Infectious Disease Journal. 40(7). 649–654. 3 indexed citations
10.
Oevermann, Lena & Pietro Sodani. (2020). Status quo of allogeneic stem cell transplantation for patients with sickle cell disease using matched unrelated donors. Hematology/Oncology and Stem Cell Therapy. 13(2). 116–119. 2 indexed citations
11.
Klaus, Anika, Annika Winkler, Lena Oevermann, et al.. (2020). Tumor-Derived Extracellular Vesicles Impair CD171-Specific CD4+ CAR T Cell Efficacy. Frontiers in Immunology. 11. 531–531. 29 indexed citations
12.
Künkele, Annette, Matthias Niemann, Axel Prüß, et al.. (2019). Donor selection in a pediatric stem cell transplantation cohort using PIRCHE and HLA‐DPB1 typing. Pediatric Blood & Cancer. 67(3). e28127–e28127. 2 indexed citations
13.
Mezger, Markus, Martin Bornhäuser, Rudolf Trenschel, et al.. (2014). KIR haplotype B donors but not KIR-ligand mismatch result in a reduced incidence of relapse after haploidentical transplantation using reduced intensity conditioning and CD3/CD19-depleted grafts. Annals of Hematology. 93(9). 1579–1586. 28 indexed citations
14.
Oevermann, Lena, Markus Mezger, Peter Lang, et al.. (2014). KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL. Blood. 124(17). 2744–2747. 98 indexed citations
15.
Oevermann, Lena, Peter Lang, Tobias Feuchtinger, et al.. (2012). Immune reconstitution and strategies for rebuilding the immune system after haploidentical stem cell transplantation. Annals of the New York Academy of Sciences. 1266(1). 161–170. 42 indexed citations
16.
Oevermann, Lena & Rupert Handgretinger. (2012). New strategies for haploidentical transplantation. Pediatric Research. 71(2-4). 418–426. 18 indexed citations
17.
Oevermann, Lena, Markus Mezger, Matthias Pfeiffer, et al.. (2011). Reduced Risk of Relapse In Pediatric ALL After Haploidentical Transplantation of T-Cell Depleted Grafts From KIR Haplotype B Donors,. Blood. 118(21). 4133–4133. 1 indexed citations
18.
Oevermann, Lena, Jan F. Scheitz, Kathleen Köck, et al.. (2008). Hematopoietic stem cell differentiation affects expression and function of MRP4 (ABCC4), a transport protein for signaling molecules and drugs. International Journal of Cancer. 124(10). 2303–2311. 48 indexed citations
19.
Grube, Markus, Gabriele Jedlitschky, Lena Oevermann, et al.. (2007). Expression of Adenosine Triphosphate-Binding Cassette (ABC)??Drug Transporters in Peripheral??Blood Cells. Clinical Pharmacokinetics. 46(6). 449–470. 81 indexed citations
20.
Böck, Barbara C., et al.. (2006). Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin. APOPTOSIS. 11(9). 1503–1512. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maryam Behfar Breakdown of academic impact, for papers by Walid Rasheed Breakdown of academic impact, for papers by LD Notarangelo Breakdown of academic impact, for papers by Bérengère de Laval Breakdown of academic impact, for papers by Sara Raponi Breakdown of academic impact, for papers by Giridharan Ramsingh Breakdown of academic impact, for papers by Toshiya Yokozawa Breakdown of academic impact, for papers by Kun Soo Lee Breakdown of academic impact, for papers by Kenneth Heym
Rankless by CCL
2026